WELLINGTON MANAGEMENT GROUP LLP - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 190 filers reported holding HERON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$471,552
-42.3%
312,286
-4.4%
0.00%
Q4 2022$816,635
-41.9%
326,654
-1.9%
0.00%
Q3 2022$1,405,000
+18.9%
332,911
-21.4%
0.00%
Q2 2022$1,182,000
-88.1%
423,593
-75.5%
0.00%
-100.0%
Q1 2022$9,894,000
-33.9%
1,729,772
+5.6%
0.00%0.0%
Q4 2021$14,957,000
-42.2%
1,638,273
-32.4%
0.00%
-50.0%
Q3 2021$25,895,000
-60.5%
2,422,422
-42.6%
0.00%
-63.6%
Q2 2021$65,521,000
-30.9%
4,221,689
-27.8%
0.01%
-35.3%
Q1 2021$94,785,000
-35.4%
5,847,348
-15.7%
0.02%
-37.0%
Q4 2020$146,798,000
+174.1%
6,935,914
+92.0%
0.03%
+145.5%
Q3 2020$53,550,000
+16.5%
3,613,296
+15.6%
0.01%
+10.0%
Q2 2020$45,970,000
+60.5%
3,125,095
+28.1%
0.01%
+25.0%
Q1 2020$28,647,000
-72.9%
2,439,996
-45.8%
0.01%
-63.6%
Q4 2019$105,699,000
+30.2%
4,497,829
+2.5%
0.02%
+22.2%
Q3 2019$81,207,000
-9.0%
4,389,517
-8.5%
0.02%
-10.0%
Q2 2019$89,191,000
-29.1%
4,797,738
-6.7%
0.02%
-28.6%
Q1 2019$125,744,000
+5.9%
5,144,988
+12.4%
0.03%
-6.7%
Q4 2018$118,750,000
-18.7%
4,577,871
-0.8%
0.03%
-3.2%
Q3 2018$146,011,000
-21.2%
4,613,317
-3.3%
0.03%
-24.4%
Q2 2018$185,321,000
+209.0%
4,770,175
+119.5%
0.04%
+192.9%
Q1 2018$59,974,0002,172,9460.01%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders